alcohol abuse. In addition, the peptide Urocortin 2 is currently in clinical trials for the treatment of acute decompensated heart failure.
Wylie was Co-Founder of two biotechnology companies. The first, Neurocrine Biosciences, is a public company based in San Diego, founded in 1992, and was based largely on his work with the CRF system. The second company, Acceleron Pharma, is a privately held company founded in 2004 and based in Cambridge, MA. Acceleron Pharma is developing protein therapeutics targeting the transforming growth factor-beta (TGF-b) superfamily of proteins. Wylie and his colleagues were the first to characterize activin A, a member of the TGF-b/BMP family of growth factors, as well as the activin receptor type II, which was the first characterized signaling receptor for this family. Wylie remained on the Board of Directors for both companies.
Professional: Wylie has accomplished much in his professional and scientific career not the least of which was his election to the National Academy of Sciences (USA) in 1992. He was a wellrespected leader in the scientific community. In addition to his election to the National Academy, he was elected as a member of several prestigious organizations, including the American Acad- Wylie made pioneering contributions to Psychiatry, particularly on the molecular, neuroendocrine and behavioral aspects of stress, and its effects on the organism. His discoveries enriched the field and the applications of his basic work had major roles in understanding mental disease. He was on the Editorial Board of Wylie Walker Vale, Jr (1941 -2012 .
Molecular Psychaitry Editorial Board Member 1996-2012
Molecular Psychiatry from the very beginning. His commitment and valuable input was greatly appreciated and will be sorely missed.
A pioneer in his professional life Wylie had this innate ability to intertwine scientific discourse with day-to-day humorous life events leaving you completely disarmed and struggling to keep up. With biting wit and unending humor, without pretense, he could relate to anyone, genuinely interested in what they had to say. We have lost a remarkable human being but he has left us a path to follow: not getting too caught up in our own trivialities, enjoying the moments that we share with each other and most importantly, taking care of family-immediate and extended. Wylie will be greatly missed by all who had the privilege of knowing this gentle soul.
